JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 8.85
-0.45 (-4.84%)
At close: Mar 27, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 292.01 million as of March 27, 2026. Its market cap has decreased by -59.95% in one year.
Market Cap
292.01M
Enterprise Value
382.13M
Revenue
744.78M
Ranking
n/a
PE Ratio
11.05
Stock Price
8.85
Market Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 292.01M, a decrease of -60.08%. That is a compound annual growth rate of -22.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 292.01M | -29.20% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mangalam Drugs & Organics | 449.68M |
| Vista Pharmaceuticals | 448.71M |
| Walpar Nutritions | 427.27M |
| Rajnish Wellness | 416.29M |
| Panjon | 394.78M |
| Murae Organisor | 353.20M |
| Sandu Pharmaceuticals | 322.29M |
| Welcure Drugs and Pharmaceuticals | 308.99M |